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Background: Over the past years, our hospitals have been
uffering from sustained endemic due to A. baumannii. Multidrug-
esistant A. baumannii has become increasingly common and
estricts the empirical antibiotic for serious nosocomial infection
NI). Sulbactam has good in vitro activity against Acinetobacter spp.
nd many studies have shown cefoperazone/sulbactam (C/S) com-
ination tobe superior to that of cefoperazone alone against clinical
solates. Sulbactam is available in combination with cefoperazone
n a ﬁxed 1:1 or 2:1 ratio. Our retrospective study evaluates the efﬁ-
acy and safety of C/S (2:1) for treating NIs caused by A. baumannii
r P. aeruginosa.
Methods: During 2006-2008, the patients from 10 hospitals
ho empirically treated with C/S (2:1) more than 72 hrs due to
. baumannii or P. aeruginosa NIs based on US-CDC criteria were
ecruited. Data on demographic, clinical features and treatment
ere collected frommedical records. Clinical outcomeswere classi-
ed as: cure, partial response, treatment failure (including hospital
ortality or change in antibiotic therapy) at 5 days after initial
/S(2:1) therapy and the end of therapy.
Results: 176 patients with a mean ± SD age of 66.2 ± 18.2
ears were enrolled for this study. There were 145 NIs due toA.
aumanniiand/or 39 NIs due toP. aeruginosa, and of these, 156
pisodes(88.6%) were nosocomial pneumonia (78% were VAP).
ighty-sevenpatients (49.4%) receivedC/S (2:1) for empirical treat-
ent on the day of diagnosis. The mean ± SD duration of C/S
reatment and dosage were 10.9 ± 6.2 days (ranged 3-38 days)
nd 3.9 + 1.3 g/day (ranged 3-6 g/day) respectively. Simultane-
usantimicrobial use (eg. polymyxin, aminoglycosides, quinolones,
arbapenems) was 18.75%. Regarding antimicrobial susceptibility,
9.4% ofA. baumanniiand 16.7% ofP. aeruginosawere resistant to
/S. The treatment failure and all-cause hospital mortality were
3.5% and 23.9% respectively. The independent predictors of treat-
ent failurewere inappropriate empirical therapy forA. baumannii
nfections (59.5%) and renal failure (52.5%) (p<.05).Nopatient expe-
ienced serious adverse events related to the administration of C/S
2:1).Conclusion:Our study reveals that C/S (2:1) appears tobeuseful
or the treatment of A. baumannii NIs.
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Investigation on the compliance with standard precautions
among nurses in Hong Kong hospitals
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Background: Standard Precautions (SPs) are applied to all
patients at all times to prevent the healthcare-associated transmis-
sion of infectious agents among patients and healthcare personnel,
regardless of their known or presumed infectious status. Currently,
SPs were adopted strictly as infection control guidelines in Hong
Kong hospitals. Nurses, who provide 24-hour direct and close
patient care, should be ﬁrstly evaluated their degree of compliance
with SPs. However, there is a paucity of research investigating this
phenomenon locally.
Methods: This survey employed descriptive and cross-sectional
design. Convenience sample of enrolled nurses from different
hospitals were invited. A self-administered questionnairewas con-
structed: demographic data (i.e. gender, nature of hospitals and
clinical experience) and compliancewith SPs. The Compliancewith
Standard Precautions Scale (CSPS; Lam, 2011) was used to assess
such compliance because itwaswell-validatedwith sound psycho-
metric properties. The 20-item CSPS encompasses 5 areas related
to the use of protective device, disposal of sharps, disposal ofwaste,
decontamination of spills and used article, and prevention of cross-
infection from person to person. The total scores range from 0–20,
with the higher score representing better compliancewith SPs. The
compliance rate refers to average compliance with all 20 items.
Results: Of the 197 invitations, 155 were returned (21.3% attri-
tion rate). Six participants who did not work in hospital or provide
direct patient carewere excluded, leaving149 sets of data for analy-
sis.Most of the participantswere female (92.6%) and 50%worked in
private hospitals. The clinical experience ranged from 1 to 22 years
(mean=7.5, SD5.61). Theoverall SPs compliance ratewas58.9% (SD
16.2). Several practices, including disposal of sharp articles, mask
wearing technique, use of gloves before exposure to body ﬂuid, and
change of gloves between patient contacts, were with over 80%
compliance rate. However, participants reported poor compliance
with disposal of sharp box (32.2%), hand-washing with antisep-
tic solution (30.2%), practice of using alcoholic hand rubs (29.5%),
taking shower in case of extensive splashing (19.7%).
Conclusion: Despite the emphasis on the signiﬁcance of SPs in
hospitals, the compliance rate of nurses still needs improvement.
Attention should be addressed particularly in those areaswith poor
compliance.
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